Our research focus is protein-protein interactions, in various physiological and pathological processes. We develop peptides that intervene with these interactions in order to learn about the interaction and also to develop peptidic pharmacological tools. We also aim to develop drugs based on our peptide design and development. Currently, our main studies are on mitochondrial proteins that are altered during cardiovascular disease.